Full-Time

Quality Operations Manager/Sr Manager

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$150.2k - $215.6kAnnually

Expert

San Carlos, CA, USA

Category
Diagnostics & Laboratory Professionals
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

You match the following Corcept Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Strong technical knowledge of analytical chemistry and pharmaceutical manufacturing technologies and processes
  • Strong experience with executed batch record review and in-depth knowledge of quality and regulatory requirements for the release of pharmaceutical products
  • Ability to work independently and communicate effectively with project team members and management groups and suppliers
  • Ability to lead or support internal and external compliance audits of suppliers, CTLs, and CMOs
  • Ability to identify compliance risk and recommend mitigations
  • Ability to author, review, and approve SOPs and other controlled documentation for compliance with applicable regulations
  • Strong statistical mindset and metric presentation
  • Proficient computer skills are needed with experience using Microsoft Word, Excel, PowerPoint, and Visio
  • Travel required
Responsibilities
  • Lead QA operations oversight of Corcept and external partners processes to support various Chemistry, Manufacturing and Controls (CMC) projects
  • Provide cGMP compliance support and guidance to cross functional team
  • Work cross-functionally with the CMC group to provide oversight and support and manage review and approvals of change controls, deviations, CAPAs, and SOPs internally and externally
  • Review and approve Master Batch Record (MBR) and executed batch records (EBR) and test data, and perform product disposition in compliance with cGMP regulations, regulatory filings, and quality agreements
  • Review and approval of validation protocols and reports (e.g., process, method, cleaning, etc.)
  • Lead and support supplier qualification
  • Perform regular update of Quality Agreements
  • Perform quality trends analysis and reports, recommending continual improvements opportunities
Desired Qualifications
  • BS or MS degree in science, engineering or related field
  • At least 10 years in the bio/pharmaceutical industry
  • At least 5-10 years in Quality Assurance
  • Knowledge in application of 21CFR211, global cGMP regulations, and ICH guidelines regarding good manufacturing practices in the development, manufacturing, testing, delivery, and control of pharmaceutical products

Corcept Therapeutics develops cortisol modulators to help regulate cortisol levels in the body, focusing on serious medical conditions like Cushing's syndrome, which is caused by excessive cortisol. Their main product, Korlym (mifepristone), is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome patients. The company distinguishes itself by investing heavily in research and development, having discovered over 1,000 selective cortisol modulators, and by supporting medical education for healthcare professionals and patients. Corcept's goal is to lead in cortisol modulation and improve treatment options for those affected by cortisol imbalances.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
  • Advancements in drug delivery systems could enhance Corcept's product efficacy.
  • The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
  • Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
  • Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours